[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::56121651.png) @BPharmCatalyst BioPharmCatalyst

BioPharmCatalyst posts on X about $cmnd, $kala, $sprc, $vrca the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::56121651/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::56121651/c:line/m:interactions.svg)

- X Week XXXXX -XXXX%
- X Month XXXXXX -XX%
- X Months XXXXXXXXX +57%
- X Year XXXXXXXXX -XX%

### Mentions: X [#](/creator/twitter::56121651/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::56121651/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XXX +17%
- X Year XXX +6.90%

### Followers: XXXXXX [#](/creator/twitter::56121651/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::56121651/c:line/m:followers.svg)

- X Week XXXXXX +0.10%
- X Month XXXXXX +0.11%
- X Months XXXXXX +3.50%
- X Year XXXXXX +5.50%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::56121651/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::56121651/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  #6483 [stocks](/list/stocks)  XXXXX% [finance](/list/finance)  XXXXX%

**Social topic influence**
[$cmnd](/topic/$cmnd) #1, [$kala](/topic/$kala) #15, [$sprc](/topic/$sprc) #4, [$vrca](/topic/$vrca) #6, [$phge](/topic/$phge) #2, [$pmcb](/topic/$pmcb) #14, [$mndr](/topic/$mndr) #7, [$meso](/topic/$meso) #1, [$tyra](/topic/$tyra) #3, [$gels](/topic/$gels) #3

**Top accounts mentioned or mentioned by**
[@artsstocks](/creator/undefined)

**Top assets mentioned**
[Taraxa (TARA)](/topic/$tara) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Cooper Companies, Inc. (COO)](/topic/$coo) [Adaptive Biotechnologies Corporation Common Stock (ADPT)](/topic/$adpt) [Curate (XCUR)](/topic/$xcur) [Integral (ITGR)](/topic/$itgr) [Dawn Protocol (DAWN)](/topic/$dawn) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Sonnet BioTherapeutics Holdings, Inc. Common Stock (SONN)](/topic/$sonn) [Allurion Technologies, Inc. (ALUR)](/topic/$alur) [MetaBeat (BEAT)](/topic/$beat) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Camp Network (CAMP)](/topic/$camp)
### Top Social Posts
Top posts by engagements in the last XX hours

"$ $KALA $SPRC $VRCA $PHGE $CMND $PMCB $MNDR $MESO $TYRA $GELS See More Pre-market Movers"  
[X Link](https://x.com/BPharmCatalyst/status/1994038563860623847)  2025-11-27T13:40Z 30.5K followers, 1586 engagements


"$ $KALA $SPRC $VRCA $PHGE $CMND $PMCB $MNDR $MESO $TYRA $GELS See More Pre-market Movers"  
[X Link](https://x.com/BPharmCatalyst/status/1994400965894516948)  2025-11-28T13:40Z 30.5K followers, 2066 engagements


"$TARA priced a $75M underwritten public offering of 13.0M shares at $XXXX each with a 30-day option to sell up to 2.0M additional shares; proceeds will support clinical development of TARA-002 and other programs with closing expected on December X 2025. $TARA $PRAX $VNDA $CAPR $IMTX $ICCM $SNSE $COO $ADPT $CYCN See More Pre-market Movers"  
[X Link](https://x.com/BPharmCatalyst/status/1996937663035662757)  2025-12-05T13:40Z 30.5K followers, 1608 engagements


"$XCUR reported Phase X results for burixafor plus propranolol and G-CSF in multiple myeloma patients undergoing autologous transplant with XXXX% achieving the primary endpoint of adequate CD34+ cell mobilization in X sessions. The rapid mobilization profile and efficacy in daratumumab-exposed patients highlight burixafors differentiated potential as a same-day mobilization agent. $XCUR $SNTI $COYA $PBM $ENSC $ENVB $VOR $ALT $BDRX $MTVA See More Pre-market Movers"  
[X Link](https://x.com/BPharmCatalyst/status/1998387212086304855)  2025-12-09T13:40Z 30.5K followers, 1581 engagements


"$ITGR posted Q3 2025 revenue of $468M up X% with X% organic growth and a XX% rise in non-GAAP EPS to $XXXX while adjusted EBITDA rose XX% to $106M. However management cut the midpoint of full-year sales guidance by $16M with Q4 organic sales expected to slow sharply to -X% to +2%. Debt rose $204M to $1.19B pushing leverage to 3.0x driven by acquisitions and the 2030 convertible note offering. $VTYX $ITGR $GNPX $NLSP $IBIO $TNGX $BIOA $NMRA $RANI $LIPO See More Biotech Updates👇"  
[X Link](https://x.com/BPharmCatalyst/status/1981458251154645159)  2025-10-23T20:30Z 30.5K followers, 1873 engagements


"$MRSN agreed to merge with $DAWN where Day One will acquire Mersana through a tender offer and second-step merger. The deal involves an upfront payment of $XXXXX per share in cash plus up to $XXXXX per share in contingent value rights (CVRs) based on clinical regulatory and commercial milestones related to Emi-Le Mersana's B7-H4 ADC. Additionally a milestone from an existing Mersana collaboration will be issued with a total equity value of about $XXX million at closing and a total deal value up to $XXX million. $MRSN $KRRO $MGNX $MGRX $CMND $APLT $AEMD $BJDX $ABSI $LUCY See More Pre-market"  
[X Link](https://x.com/BPharmCatalyst/status/1988965134992130204)  2025-11-13T13:40Z 30.5K followers, 2071 engagements


"$JANX announced updated interim data from its Phase 1a and Phase 1b clinical trials of JANX007 a PSMA-directed TRACTr in patients with metastatic castration-resistant prostate cancer (mCRPC). $PLRZ $JANX $NIVF $SONN $GUTS $CMND $MGRX $BNR $ARMP $MTVA See More Biotech Updates👇"  
[X Link](https://x.com/BPharmCatalyst/status/1995973132260143323)  2025-12-02T21:47Z 30.5K followers, 2029 engagements


"$ALUR reported initial 12-month results from a study combining its Smart Capsule program with low-dose tirzepatide showing XX% average total weight loss and a XX% increase in lean body mass with full patient adherence and no early discontinuations $ALUR $CTNM $ESPR $CMND $KTTA $TPST $KZIA $PMBC $CLSD $ADTX See More Biotech Updates👇"  
[X Link](https://x.com/BPharmCatalyst/status/1993432139363197340)  2025-11-25T21:30Z 30.5K followers, 1970 engagements


"$BEAT secured FDA 510(k) clearance for its 12-lead ECG synthesis software following a successful appeal of a prior NSE ruling. The breakthrough cable-free credit-card-sized device enables at-home clinical-grade arrhythmia assessment unlocking key growth initiatives and positioning the company to transform remote cardiac care. $BEAT $MODD $DYN $DARE $FULC $PMN $ENVB $CVKD $WOK $NIVF See More Pre-market Movers"  
[X Link](https://x.com/BPharmCatalyst/status/1998749615017861293)  2025-12-10T13:40Z 30.5K followers, 1710 engagements


"$RYTM will report preliminary Phase X data for setmelanotide in Prader-Willi syndrome during a live webcast on December XX offering an early look at potential expansion of its rare disease pipeline. $MBRX $MODD $RYTM $GRI $CRBP $CMND $IBIO $CAMP $ATPC $IMRN See More Biotech Updates👇"  
[X Link](https://x.com/BPharmCatalyst/status/1998867916276572499)  2025-12-10T21:30Z 30.5K followers, 1960 engagements